Drug Patent Expirations in May 2011 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration OPTIVAR Meda Pharms azelastine hydrochloride 5,164,194*PED May 1, 2011 ASTELIN Meda Pharms azelastine hydrochloride 5,164,194*PED May 1, 2011 ENTOCORT EC Astrazeneca budesonide 6,423,340*PED May 15, 2011 ALORA Watson Labs estradiol 5,227,169 May 17, 2011 […]
The May 2011 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper: Volume 17, Issue 2 Editorial Building biotechnology in Okinawa PDF Yali Friedman Commentary Startup America: What it includes and opportunities for innovators PDF David B Orange Singapore – Home base […]
This is a guest post by Jurgita Ashley You are a small company ready to take a leap into the public market, whether it is for growth, liquidity or to attract greater investor interest. But, oh man, those dollar figures for IPOs would make anyone’s head spin. But wait, don’t discount it yet as a […]
Today, the Biotechnology Industry Organization (BIO) announced a distinguished panel of judges who will evaluate nominations for the third annual Biotech Humanitarian Award and select the 2011 Honoree. BIO created the Award to recognize an everyday hero who has helped to heal, fuel and feed the planet through their work in or support of biotechnology. […]
Drug Patent Expirations in April 2011 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration AROMASIN Pharmacia And Upjohn exemestane 4,808,616 Apr 1, 2011 VIVELLE Novartis estradiol 5,300,291 Apr 5, 2011 DEFINITY Lantheus Medcl perflutren 5,547,656 Apr 5, 2011 DEFINITY Lantheus Medcl perflutren 6,773,696 Apr 5, 2011 DEFINITY Lantheus […]
Here’s a copy of the talk I gave at the American Chemical Society meeting, on using patent information to track globalization: Using patent information to track globalization Check out it. I think the findings will surprise you!
I will be giving a talk on “Using patent information to track globalization” at the ACS conference in Anaheim next week. The talk is part of the ACS Division of Chemistry and Law session on What Can Patent Information Do For Scientists, and is based on analysis of data from DrugPatentWatch. I look forward to […]
Fortune magazine recently published an article on the growing trend of generic companies challenging pharmaceutical drug patents. I enjoyed working with the writer to help layout the industry landscape, and share my knowledge of drug patents and trends from DrugPatentWatch.com. It’s a good read, and it does an excellent job of laying out the legal, […]
DrugPatentWatch.com is proud to announce the addition of a vital new feature to it’s rich collection of drug patent intelligence tools: a Paragraph IV Certification newsfeed.
I had the pleasure of serving as a judge for last year’s Biotech Humanitarian Award, and now it’s time for nomination’s for this year’s award. The Award will be given to an individual who, through their work in or support of biotechnology, is harnessing its potential to heal, fuel or feed the planet. In the […]